Histopathological diagnosis of colitis: differential diagnosis and interpretation

Česká verzia

Authors: Ondřej Fabián ^1,2; Kateřina Kamaradová ^3,4
Authors place of work: Pracoviště klinické a transplantační patologie, Institut klinické a experimentální medicíny, Praha ¹; Ústav patologie a molekulární medicíny 3. LF UK a FTN, Fakultní Thomayerova nemocnice, Praha ²; AeskuLab Patologie k. s., Praha ³; Fingerlandův ústav patologie, Fakultní nemocnice Hradec Králové ⁴
Published in the journal: Čes.-slov. Patol., 58, 2022, No. 1, p. 11-26
Category: Reviews Article

Zánětlivá onemocnění tlustého střeva patří mezi častou problematiku v rutinní bioptické praxi. Jejich interpretace může být náročná s ohledem na omezené a značně překryvné spektrum morfologických změn, kterými se mohou jednotlivá onemocnění manifestovat. Adekvátně posouzená biopsie střevní sliznice však stále představuje důležitý článek multidisciplinárního diagnostického řetězu a rozpoznání základních morfologických vzorců nenádorových střevních onemocnění by tak mělo patřit do výbavy každého patologa. Tento doškolovací text si klade za cíl přiblížit systematický přístup k histopatologickému hodnocení kolitid a zaměřuje se zejména na onemocnění jiná než nespecifické střevní záněty (IBD).

Summary

Non-neoplastic inflammatory conditions of a large bowel mucosa are commonly encountered in bioptic practice. Their interpretation yields many challenges especially due to their limited and often non-specific and overlapping morphological spectrum. However, an accurate assessment of colonic biopsy still represents an important part of multidisciplinary diagnostic process and identification and subsequent interpretation of proper morphological pattern should be in a competence of any routine pathologist. This article provides systematic approach to histopathological assessment of inflammatory diseases of colonic mucosa, focusing mainly on diagnoses other than inflammatory bowel disease (IBD).

Keywords:

Biopsy – Colitis – inflammation – histopathology – differential diagnosis

Zdroje

1. Feakins RM, British Society of Gastroenterology. Inflammatory bowel disease biopsies: updated British Society of gastroenterology reporting guidelines. J Clin Pathol 2013; 66(12): 1005–1026.

2. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of gastroenterology initiative. J Clin Pathol 1997; 50(2): 93–105.

3. Assarzadegan N, Montgomery E, Pezhouh MK. Colitides: diagnostic challenges and a pattern based approach to differential diagnosis. Diagn Histopathol 2017; 23(12): 536-543.

4. Jouret-Mourin A, Faa G, Geboes K. Colitis: A Practical Approach to Colon and Ileum Biopsy Interpretation (2nd ed). Berlin: Springer; 2018.

5. Montgomery E, Voltaggio L. Biopsy Interpretation of the Gastrointestinal Tract Mucosa: Non-Neoplastic (Biopsy Interpretation Series) (2nd ed). Philadelphia, PA: Lippincott Williams & Wilkins; 2011.

6. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011; 140(4): 1155–1165.

7. Odze RD, Goldblum JR. Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract, and pancreas (3rd ed). Philadelphia, PA: Saunders/Elsevier; 2015.

8. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128(1): 3-20.

9. Polydorides AD, Banner BF, Hannaway PJ Yantiss RK. Evaluation of site-specific and seasonal variation in colonic mucosal eosinophils. Hum Pathol 2008; 39(6): 832–836.

10. Pascal RR, Gramlich TL, Parker KM Gansler TS. Geographic variations in eosinophil concentration in normal colonic mucosa. Mod Pathol 1997; 10(4): 363–365.

11. Moore M, Feakins RM, Lauwers GY. Non-neoplastic colorectal disease biopsies: evaluation and differential diagnosis. J Clin Pathol 2020; 73(12): 783-792.

12. Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg Pathol 1989; 13(11): 966– 984.

13. Leriche M, Devroede G, Sanchez G, Rossano J. Changes in the rectal mucosa induced by hypertonic enemas. Dis Colon Rectum 1978; 21(4): 227-236.

14. Driman DK, Preiksaitis HG. Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol 1998; 29(9): 972-978.

15. Khor TS, Fujita H, Nagata K, Shimizu M, Lauwers GY. Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded. J Gastroenterol 2012; 47(3): 226-248.

16. Greenson JK, Stern RA, Carpenter SL, Barnett JL. The clinical significance of focal active colitis. Hum Pathol 1997; 28(6): 729–733.

17. Shetty S, Anjarwalla SM, Gupta J, Foy CJ, Shaw IS, Valori RM, Shepherd NA. Focal active colitis: a prospective study of clinicopathological correlations in 90 patients. Histopathology 2011; 59(5): 850–856.

18. Marginean EC. The Ever-Changing Landscape of Drug-Induced Injury of the Lower Gastrointestinal Tract. Arch Pathol Lab Med 2016; 140(8): 748-758.

19. Baroudjian B, Lourenco N, Pages C, et al. Anti-PD1-induced collagenous colitis in a melanoma patient. Melanoma Res 2016; 26(3): 308-311.

20. Chen JH, Pezhouh MK, Lauwers GY, Masia R. Histopathologic features of colitis due to immunotherapy with anti-PD-1 antibodies. Am J Surg Pathol 2017; 41(5): 643-654.

21. Villanacci V, Antonelli E, Reboldi G, Salemme M, Casella G, Bassotti G. Endoscopic biopsy samples of naïve “colitides” patients: role of basal plasmacytosis. J Crohns Colitis 2014; 8(11): 1438–1443.

22. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013; 7(10): 827-851.

23. Goldstein NS, Leon-Armin C, Mani A. Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn’s colitis. Am J Surg Pathol 2000; 24(5): 668–675.

24. Geraghty JM, Talbot IC. Diversion colitis: histological features in the colon and rectum after defunctioning colostomy. Gut 1991; 32(9): 1020–1023.

25. Edwards CM, George B, Warren B. Diversion colitis—new light through old windows. Histopathology 1999; 34(1): 1–5.

26. Asplund S, Gramlich T, Fazio V, Petras R. Histologic changes in defunctioned rectums in patients with inflammatory bowel disease: a clinicopathologic study of 82 patients with long-term follow-up. Dis Colon Rectum 2002; 45(9): 1206–1213.

27. Price AB, Davies DR. Pseudomembranous colitis. J Clin Pathol 1977; 30(1): 1–12.

28. Price AB. Histopathology of clostridial gut disease in man. In: Borriello SP, ed. Clostridia in gastrointestinal disease (1st ed). Boca Raton: CRC; 1985.

29. Dignan CR, Greenson JK. Can ischemic colitis be differentiated from C. difficile colitis in biopsy specimens? Am J Surg Pathol 1997; 21(6): 706–710.

30. Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon 2015; 61(5): 181–206.

31. Yamazaki T, Shirai Y, Tada T, Sasaki M, Sakai Y, Hatakeyama K. Ischemic colitis arising in watershed areas of the colonic blood supply: a report of two cases. Surg Today 1997; 27(5): 460-462.

32. Carlson RM, Madoff RD. Is ‘‘ischemic’’ colitis ischemic? Dis Colon Rectum 2011; 54(3): 370– 373.

33. MacDonald PH. Ischaemic colitis. Best Pract Res Clin Gastroenterol 2002; 16(1): 51–61.

34. Nikolic AL, Keck JO. Ischaemic colitis: uncertainty in diagnosis, pathophysiology and management. ANZ J Surg 2018; 88(4): 278- 283.

35. Patel S, Voltaggio L. A practical approach to colitis. Diagn Histopathol 2011; 17(9): 376–385.

36. Villanacci V, Casella G, Bassotti G. The spectrum of drug-related colitides: important entities, though frequently overlooked. Dig Liver Dis 2011; 43(7): 523–528.

37. Boutros HH, Pautler S, Chakrabarti S. Cocaine- induced ischemic colitis with small-vessel thrombosis of colon and gallbladder. J Clin Gastroenterol 1997; 24(1): 49-53.

38. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 1997; 21(1): 60-69.

39. Byrnes K, Khararjian A, Mannan AASR, Arnold M, Voltaggio L. Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation. Int J Surg Pathol 2020; 28(4): 361-366.

40. Xia R, Zhang X. Neutropenic enterocolitis: A clinico-pathological review. World J Gastrointest Pathophysiol 2019; 10(3): 36–41.

41. Russo P, Ruchelli ED, Piccoli DA. Pathology of Pediatric Gastrointestinal and Liver Disease (2nd ed). Berlin: Springer; 2014.

42. Leupin N, Curschmann J, Kranzbuhler H, Maurer CA, Laissue JA, Mazzucchelli L. Acute radiation colitis in patients treated with short-term preoperative radiotherapy for rectal cancer. Am J Surg Pathol 2002; 26(4): 498–504.

43. Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology 1985; 9(5): 517–534.

44. Martin CJ, Parks TG, Biggart JD. Solitary rectal ulcer syndrome in Northern Ireland. 1971- 1980. Br J Surg 1981; 68(10): 744–747.

45. Warren BF, Dankwa EK, Davies JD. ’Diamond- shaped’ crypts and mucosal elastin: helpful diagnostic features in biopsies of rectal prolapse. Histopathology 1990; 17(2): 129–134.

46. Saul SH, Sollenberger LC. Solitary rectal ulcer syndrome. Its clinical and pathological underdiagnosis. Am J Surg Pathol 1985; 9(6): 411–421.

47. Rubio CA. A simple method to evaluate the thickness of collagen in collagenous colitis. Scand J Gastroenterol 2000; 35(2): 223–224.

48. Langner C, Aust D, Ensari A, et al. Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 2015; 66(5): 613–626.

49. Guagnozzi D, Landolfi S, Vicario M. Towards a new paradigm of microscopic colitis: incomplete and variant forms. World J Gastroenterol 2016; 22(38): 8459–8471.

50. Saad E, Shobar R, Mutlu EA. Collagenous colitis development occurs after long standing mucosal healing in IBD with TNF-α inhibitors, and could be due to exaggerated healing response from excess TNF-α inhibition. Med Hypotheses 2019; 123: 90-94.

51. Geboes K. Lymphocytic, collagenous and other microscopic colitides: pathology and the relationship with idiopathic inflammatory bowel diseases. Gastroenterol Clin Biol 2008; 32(8-9): 689–694.

52. Bjørnbak C, Engel PJH, Nielsen PL Munck LK. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011; 34(10): 1225–1234.

53. Rasmussen J, Engel PJH, Wildt S Fiehn AMK, Munck LK. The temporal evolution of histological abnormalities in microscopic colitis. J Crohns Colitis 2016; 10(3): 262–268.

54. Treanor D, Gibbons D, O’ Donoghue DP, Sheahan K. Pseudomembranes in collagenous colitis. Histopathology 2001; 38: 83–84.

55. Libbrecht L, Croes R, Ectors N, Staels F, Geboes K. Microscopic colitis with giant cells. Histopathology 2002; 40(4): 335–338.

56. García-González R, Fernández FA, Garijo MF, Val-Bernal JF. Amyloidosis of the rectum mimicking collagenous colitis. Pathol Res Pract 1998; 194(10): 731–735.

57. Lamps LW, Lazenby AJ. Colonic epithelial lymphocytosis and lymphocytic colitis: descriptive histopathology versus distinct clinicopathologic entities. Adv Anat Pathol 2000; 7(4): 210–213.

58. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989; 20(1): 18–28.

59. Fiehn A-MK, Engel U, Holck S, Munck LK, Engel PJH. CD3 immunohistochemical staining in diagnosis of lymphocytic colitis. Hum Pathol 2016; 48: 25–31.

60. Fiehn A-MK, Clausen LN, Engel U, Wildt S, Munck LK, Kristensson M, Engel PJH. Is revision of cutoff values needed when using CD3 immunohistochemical staining in histopathologic diagnosis of lymphocytic colitis? Hum Pathol 2019; 84: 115–123.

61. Ayata G, Ithamukkala S, Sapp H, et al. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol 2002; 26(11): 1414–1423.

62. Rubio CA, Lindholm J. Cryptal lymphocytic coloproctitis: a new phenotype of lymphocytic colitis? J Clin Pathol 2002; 55(2): 138–140.

63. Brown IS, Lambie DLJ. Microscopic colitis with giant cells: a clinico-pathological review of 11 cases and comparison with microscopic colitis without giant cells. Pathology 2008; 40(7): 671–675.

64. Fernández-Bañares F, Salas A, Esteve M. Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis. J Crohns Colitis 2008; 2(4): 343–347.

65. Green PH, Yang J, Cheng J, Lee AR, Harper JW, Bhagat G. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009; 7(11): 1210–1216.

66. Marteau P, Lavergne-Slove A, Lemann M, et al. Primary ileal villous atrophy is often associated with microscopic colitis. Gut 1997; 41(4): 561–564.

67. Leung ST, Chandan VS, Murray JA, Wu TT. Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol 2009; 33(5): 788–798.

68. Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med 2006; 130(3): 362–367.

69. Ramsay DB, Stephen S, Borum M, Voltaggio L, Doman DB. Mast cells in gastrointestinal disease. Gastroenterol Hepatol (NY) 2010; 6(12): 772–777.

70. Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol 2001; 36(2): 174–179.

71. Schwab D, Raithel M, Hahn EG. Evidence for mast cell activation in collagenous colitis. Inflamm Res 1998; 47(Suppl 1): S64–65.

72. Blirando K, Milliat F, Martelly I, Sabourin JC, Benderitter M, Francois A. Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am J Pathol 2011; 178(2): 640–651.

73. Griffin PM, Olmstead LC, Petras RE. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology 1990; 99(1): 142–149.

74. Pardanani A. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011; 86(4): 362–371.

75. Hahn HP, Hornick JL. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol 2007; 31(11): 1669-1676.

76. Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, Castells MC, Hornick JL. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol 2014; 38(6): 832-843.

77. Lepidi H, Fenollar F, Gerolami R, et al. Whipple’s Disease: Immunospecific and Quantitative Immunohistochemical Study of Intestinal Biopsy Specimens. Hum Pathol 2003; 34(6): 589-596.

78. Brown I, Kumarasinghe MP. Granulomas in the gastrointestinal tract: deciphering the Pandora’s box. Virchows Arch 2018; 472(1): 3-14.

79. Rotterdam H, Korelitz BI, Sommers SC. Microgranulomas in grossly normal rectal mucosa in Crohn’s disease. Am J Clin Pathol 1977; 67(6): 550–554.

80. Lorenzi L, Bisoffi Z, Bortesi L, Zamboni G, Liut F, Villanacci V. Schaumann bodies in Crohn’s disease: a case report and review of the literature. J Crohn’s Colitis 2012; 6(7): 800– 803.

81. Ghrenassia E, Mekinian A, Chapelon-Albric C, et al. Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore) 2016; 95(29): e4279.

82. Gonzalez RS, Salaria SN, Bohannon CD, Huber AR, Feely MM, Shi C. PD-1 inhibitor gastroenterocolitis: case series and appraisal of ‘immunomodulatory gastroenterocolitis’. Histopathology 2017; 70(4): 558–567.

83. Alimchandani M, Lai JP, Aung PP, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 2013; 37(9): 1365–1372.

84. Hussain N, Quezado M, Huizing M, Geho D, White JG, Gahl W, Mannon P. Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype. Clin Gastroenterol Hepatol 2006; 4(1): 73–80.

85. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007; 31(12): 1800–1812.

86. Sood A, Midha V, Singh A. Differential diagnosis of Crohn’s disease versus ileal tuberculosis. Curr Gastroenterol Rep 2014; 16(11): 418.

87. Franco DL, Ruff K, Mertz L, Lam-Himlin DM, Heigh R. Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol 2014; 8(3): 329–336.

88. Haworth SJ, Pusey CD. Severe intestinal involvement in Wegener’s granulomatosis. Gut 1984; 25(11): 1296–1300.

89. Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet’s disease: a review. World J Gastroenterol 2015; 21(13): 3801–3812.

90. Colombat M, Imbert A, Bruneval P, Chatelain D, Gontier MF. Giant cell arteritis localized to the colon associated with Crohn’s disease. Histopathology 2001; 38(1): 21–24.

91. Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009; 58(5): 721–732.

92. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004; 113(1): 11–28.

93. Machida HM, Catto Smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathologic aspects. J Pediatr Gastroenterol Nutr 1994; 19(1): 22–26.

94. Matsushita T, Maruyama R, Ishikawa N, et al. The number and distribution of eosinophils in the adult human gastrointestinal tract: a study and comparison of racial and environmental factors. Am J Surg Pathol 2015; 39(4): 521-527.

95. Assarzadegan N, Montgomery E, Pezhouh MK. Colitides: diagnostic challenges and a pattern based approach to differential diagnosis. Diagn Histopathol 2017; 23(12): 536– 543.

96. Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol 2011; 18(5): 335–348.

97. Clouse RE, Alpers DH, Hockenbery DM, DeSchryver-Kecskemeti K. Pericrypt eosinophilic enterocolitis and chronic diarrhea. Gastroenterology 1992; 103(1): 168–176.

98. Huang L, Appleton JA. Eosinophils in helminth infection: Defenders and Dupes. Trends Parasitol 2016; 32(10): 798–807.

99. Anttila VJ, Valtonen M. Carbamazepine-Induced eosinophilic colitis. Epilepsia 1992; 33(1): 119–121.

100. Lange P, Oun H, Fuller S, Turney JH. Eosinophilic colitis due to rifampicin. Lancet 1994; 344(8932): 1296–1297.

101. Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010; 126(1): 39-44.

102. Washington K, Jagasia M. Pathology of graft-versus-host disease in the gastrointestinal tract. Hum Pathol 2009; 40(7): 909–917.

103. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus- host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12(1): 31– 47.

104. Karamchandani DM, Chetty R. Apoptotic colopathy: a pragmatic approach to diagnosis. J Clin Pathol 2018; 71(12): 1033-1040.

105. Masia R, Peyton S, Lauwers GY, Brown I. Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. Am J Surg Pathol 2014; 38(10):1319–1329.

106. Conrad MA, Carreon CK, Dawany N, Russo P, Kelsen JR. Distinct Histopathological Features at Diagnosis of Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis 2019; 13(5): 615-625.

107. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996; 110(6): 1820- 1834.